Duncker Streett & Co. Inc. Boosts Stake in HCP, Inc. (HCP)

Duncker Streett & Co. Inc. grew its position in shares of HCP, Inc. (NYSE:HCP) by 1.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 22,690 shares of the real estate investment trust’s stock after acquiring an additional 402 shares during the period. Duncker Streett & Co. Inc.’s holdings in HCP were worth $710,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HCP. Massey Quick Simon & CO. LLC bought a new position in shares of HCP during the 1st quarter valued at $25,000. Pacific Center for Financial Services increased its stake in shares of HCP by 123.5% in the 4th quarter. Pacific Center for Financial Services now owns 894 shares of the real estate investment trust’s stock worth $25,000 after purchasing an additional 494 shares in the last quarter. Executive Wealth Management LLC purchased a new stake in shares of HCP in the 4th quarter worth $30,000. Rational Advisors LLC increased its stake in shares of HCP by 336.7% in the 4th quarter. Rational Advisors LLC now owns 1,262 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 973 shares in the last quarter. Finally, Pearl River Capital LLC purchased a new stake in shares of HCP in the 4th quarter worth $35,000. Hedge funds and other institutional investors own 96.95% of the company’s stock.

Shares of HCP stock traded up $0.08 during trading on Wednesday, reaching $31.33. 1,810,000 shares of the stock traded hands, compared to its average volume of 3,077,439. The firm has a market cap of $14.94 billion, a price-to-earnings ratio of 17.21, a PEG ratio of 6.88 and a beta of 0.43. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.90. HCP, Inc. has a 52-week low of $22.90 and a 52-week high of $32.23.

HCP (NYSE:HCP) last issued its quarterly earnings data on Wednesday, May 1st. The real estate investment trust reported $0.44 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.01. HCP had a return on equity of 18.05% and a net margin of 59.96%. The firm had revenue of $436.15 million during the quarter, compared to analyst estimates of $442.20 million. During the same quarter last year, the business posted $0.48 earnings per share. The business’s quarterly revenue was down 9.0% compared to the same quarter last year. On average, equities analysts expect that HCP, Inc. will post 1.73 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 21st. Investors of record on Monday, May 6th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.72%. The ex-dividend date was Friday, May 3rd. HCP’s payout ratio is 81.32%.

Several equities research analysts have recently commented on HCP shares. Morgan Stanley set a $32.00 price objective on HCP and gave the stock a “hold” rating in a research note on Thursday, March 28th. BMO Capital Markets reiterated a “buy” rating and issued a $33.00 price target on shares of HCP in a research note on Wednesday, February 13th. TheStreet lowered HCP from a “b-” rating to a “c+” rating in a research note on Tuesday, May 7th. Finally, Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a research note on Thursday, March 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $29.50.

In related news, Director Christine Garvey sold 3,405 shares of the stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $29.80, for a total value of $101,469.00. Following the completion of the transaction, the director now owns 5,348 shares of the company’s stock, valued at approximately $159,370.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.13% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: This report was posted by Sundance Herald and is owned by of Sundance Herald. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at https://sundanceherald.com/2019/05/22/hcp-inc-hcp-stake-lifted-by-duncker-streett-co-inc.html.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: What is the Ex-Dividend Date in Investing?

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply